Facilitating immune reaction in pregnancy and cancer.
D000026:Abortion, Habitual / Q000276:immunology; D002822:Choriocarcinoma / Q000276:immunology; D005260:Female; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006801:Humans; D006828:Hydatidiform Mole / Q000276:immunology; D007112:Immunity, Maternally-Acquired; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000378:metabolism; D007518:Isoantibodies / Q000096:biosynthesis / Q000502:physiology*; D007957:Leukocyte Adherence Inhibition Test; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000145:classification; D008297:Male; D010051:Ovarian Neoplasms / Q000276:immunology; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000276:immunology*; D014327:Trophoblasts / Q000276:immunology / Q000378:metabolism; D002583:Uterine Cervical Neoplasms / Q000276:immunology; D014594:Uterine Neoplasms / Q000276:immunology
D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D007074:Immunoglobulin G; D007518:Isoantibodies